Sodium nitrite orchestrates macrophage mimicry of tongue squamous carcinoma cells to drive lymphatic metastasis
- PMID: 39799274
- PMCID: PMC11833070
- DOI: 10.1038/s41416-024-02923-0
Sodium nitrite orchestrates macrophage mimicry of tongue squamous carcinoma cells to drive lymphatic metastasis
Abstract
Background: Tongue squamous cell carcinoma (TSCC) is a malignant oral cancer with unclear pathogenesis that shows a tendency for early-stage lymphatic metastasis. This results in a poor prognosis, with a low 5-year survival rate. Dietary sodium nitrite (NaNO2) has proposed associations with disease, including cancer. However, a direct relationship between NaNO2 and TSCC has not been established.
Methods: In vitro and in vivo assays were used to investigate the role of NaNO2 in TSCC. Protein expression in TSCC specimens was detected by immunohistochemistry and immunofluorescence. The molecular mechanism was determined using RT-qPCR, western blot, RNA-seq, luciferase reporter assays, migration assays, and FACS analysis. More detail of methods can be found in the Materials and methods section.
Results: The data in this study showed that NaNO2 did not initiate carcinogenesis in the tongue but improved the lymphatic metastatic potential of TSCC cells in the specified experimental period. During metastasis to lymph nodes, monocyte-macrophage markers were upregulated in TSCC cells, whereas keratin markers were downregulated. Specifically, expression of the CD68 gene was high in TSCC cells following NaNO2-induced TSCC phenotypic switching. These phenotypic changes were associated with activation of transcription factor cyclic-AMP response binding protein (CREB1), which directly targets CD68 transcription. Furthermore, blocking CREB1 activity either through gene knockout or specific inhibitor treatment decreased the migration ability of TSCC cells and suppressed CD68 expression.
Conclusions: Our findings highlight the role of NaNO2 in enabling macrophage mimicry in TSCC cells through the CREB1-CD68 signaling pathway, which promotes lymphatic metastasis. Shedding light on drivers of lymphatic metastasis in TSCC and providing a new perspective on dietary strategies to improve outcomes of patients with TSCC.
© 2025. The Author(s), under exclusive licence to Springer Nature Limited.
Conflict of interest statement
Competing interests: The authors declare no competing interests. Ethics approval and consent to participate:: The human specimen collection in this study was followed the protocol approved by the ethics committee of Guanghua Hospital, Sun Yat-sen University (approval No. 2010-9), and written informed consent was obtained from the patient in accordance with ethical guidelines. All animal experimental protocols were performed following by the Animal Ethics Committee of Sun Yat-sen University (approval No. 2022002118).
Similar articles
-
CXCR4/CXCL12 axis promotes lymphatic metastasis in tongue squamous cell carcinoma via PI3K/AKT signaling pathway.J Transl Med. 2025 Jul 8;23(1):757. doi: 10.1186/s12967-025-06707-9. J Transl Med. 2025. PMID: 40629333 Free PMC article.
-
Dihydroartemisinin inhibited tongue squamous cell carcinoma progression and tongue-to-lymph node metastasis through inhibiting RalB expression.Acta Histochem. 2025 Sep;127(3):152276. doi: 10.1016/j.acthis.2025.152276. Epub 2025 Jun 30. Acta Histochem. 2025. PMID: 40592008
-
The Src family kinase inhibitor drug Dasatinib and glucocorticoids display synergistic activity against tongue squamous cell carcinoma and reduce MET kinase activity.Cell Commun Signal. 2025 Jun 19;23(1):293. doi: 10.1186/s12964-025-02129-8. Cell Commun Signal. 2025. PMID: 40537792 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340. Health Technol Assess. 2006. PMID: 16959170
References
-
- Chi AC, Day TA, Neville BW. Oral cavity and oropharyngeal squamous cell carcinoma-an update. CA Cancer J Clin. 2015;65:401–21. - PubMed
MeSH terms
Substances
Grants and funding
- 2019B1515210015/Guangdong Science and Technology Department (Science and Technology Department, Guangdong Province)
- KJZD20230923114802005/Shenzhen Science and Technology Innovation Commission
- 2023M744083/China Postdoctoral Science Foundation
- 31871413/National Natural Science Foundation of China (National Science Foundation of China)
- 2023M744083/Postdoctoral Research Foundation of China (China Postdoctoral Research Foundation)
LinkOut - more resources
Full Text Sources